Danske Bank A S Lowers Stock Holdings in HealthEquity, Inc. $HQY

Danske Bank A S lowered its holdings in HealthEquity, Inc. (NASDAQ:HQYFree Report) by 94.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 700 shares of the company’s stock after selling 12,409 shares during the period. Danske Bank A S’s holdings in HealthEquity were worth $64,000 as of its most recent SEC filing.

A number of other institutional investors have also recently added to or reduced their stakes in HQY. AQR Capital Management LLC grew its position in HealthEquity by 148.5% during the second quarter. AQR Capital Management LLC now owns 1,107,448 shares of the company’s stock valued at $116,016,000 after acquiring an additional 661,795 shares during the period. Westfield Capital Management Co. LP grew its position in HealthEquity by 35.7% during the third quarter. Westfield Capital Management Co. LP now owns 1,716,658 shares of the company’s stock valued at $162,688,000 after acquiring an additional 451,450 shares during the period. Woodline Partners LP purchased a new stake in HealthEquity during the third quarter valued at about $26,193,000. Vanguard Group Inc. grew its position in HealthEquity by 2.9% during the third quarter. Vanguard Group Inc. now owns 8,746,255 shares of the company’s stock valued at $828,883,000 after acquiring an additional 243,549 shares during the period. Finally, Marshall Wace LLP grew its position in HealthEquity by 460.2% during the third quarter. Marshall Wace LLP now owns 293,182 shares of the company’s stock valued at $27,785,000 after acquiring an additional 240,847 shares during the period. Hedge funds and other institutional investors own 99.55% of the company’s stock.

HealthEquity Price Performance

Shares of NASDAQ HQY opened at $83.99 on Friday. HealthEquity, Inc. has a 1-year low of $72.76 and a 1-year high of $116.65. The business has a 50-day moving average of $81.30 and a 200-day moving average of $87.78. The company has a debt-to-equity ratio of 0.45, a current ratio of 3.27 and a quick ratio of 3.27. The company has a market capitalization of $7.10 billion, a price-to-earnings ratio of 34.14, a PEG ratio of 1.51 and a beta of 0.19.

HealthEquity (NASDAQ:HQYGet Free Report) last issued its earnings results on Tuesday, March 17th. The company reported $0.95 earnings per share for the quarter, topping the consensus estimate of $0.90 by $0.05. HealthEquity had a return on equity of 13.86% and a net margin of 16.39%.The company had revenue of $334.59 million during the quarter, compared to the consensus estimate of $332.48 million. The company’s revenue was up 7.3% compared to the same quarter last year. On average, equities analysts anticipate that HealthEquity, Inc. will post 3.84 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

HQY has been the subject of a number of research reports. UBS Group set a $110.00 price target on HealthEquity in a research report on Tuesday, February 17th. Deutsche Bank Aktiengesellschaft boosted their price target on HealthEquity from $120.00 to $128.00 and gave the company a “buy” rating in a research report on Thursday, March 19th. BMO Capital Markets raised HealthEquity from a “market perform” rating to an “outperform” rating and boosted their price target for the company from $85.00 to $105.00 in a research report on Thursday, April 9th. BTIG Research lowered their price target on HealthEquity from $130.00 to $110.00 and set a “buy” rating for the company in a research report on Tuesday, February 17th. Finally, JPMorgan Chase & Co. lowered their price target on HealthEquity from $129.00 to $123.00 and set an “overweight” rating for the company in a research report on Wednesday, March 18th. One analyst has rated the stock with a Strong Buy rating, twelve have given a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $111.79.

View Our Latest Report on HQY

HealthEquity Profile

(Free Report)

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.

Read More

Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQYFree Report).

Institutional Ownership by Quarter for HealthEquity (NASDAQ:HQY)

Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.